Evidence map›Paper›PMID 39199558›Full record

ArticleCancers2024

Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients.

Didier Decaudin, Fariba Némati, Julien Masliah Planchon, Agathe Seguin-Givelet, Marine Lefevre, Vesnie Etienne, Harry Ahnine, Quentin Peretti, Laura Sourd, Rania El-Botty and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Didier DecaudinLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
Fariba NématiLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.ORCID 0000-0001-8879-7592
Julien Masliah PlanchonDepartment of Genetic, Institut Curie, 75005 Paris, France.ORCID 0000-0002-5596-3926
Agathe Seguin-GiveletDepartment of Thoracic Surgery, Curie-Montsouris Thorax Institute, Institut Mutualiste Montsouris, 75014 Paris, France.ORCID 0000-0002-2906-4433
Marine LefevreDepartment of Pathology, Institut Mutualiste Montsouris, 75014 Paris, France.ORCID 0000-0003-2216-1481
Vesnie EtienneLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
Harry AhnineLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
Quentin PerettiLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
Laura SourdLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
Rania El-BottyLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
Lea HuguetLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
Sarah LaghaDepartment of Medical Oncology, Institut Curie, 75005 Paris, France.ORCID 0009-0001-2085-7787
Nadia HegaratDepartment of Medical Oncology, Institut Curie, 75005 Paris, France.ORCID 0009-0008-7612-8381
Sergio Roman-RomanDepartment of Translationnal Research, Institut Curie, PSL University Paris, 75006 Paris, France.
Ivan BiècheDepartment of Genetic, Institut Curie, 75005 Paris, France.
Nicolas GirardDepartment of Medical Oncology, Institut Curie, 75005 Paris, France.
Elodie MontaudonLaboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.ORCID 0009-0002-5197-8300

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of chemotherapy and targeted therapy has been validated in non-small-cell lung cancer (NSCLC) patients with

Indexed as

chemotherapycombinationNGS-defined targeted therapyPDXssquamous NSCLC

Identifiers

PMID39199558
PMCPMC11352497

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.